Literature DB >> 29471607

Mushroom Poisoning by Macrolepiota neomastoidea.

So Yeon Kim1, Yang Hyun Baek1, Sang Young Han1, Sung Wook Lee1, Young Hoon Roh2, Kwan Woo Kim2, Sung Hwa Kang2, Jin Sook Jeong3.   

Abstract

There are currently over 5,000-known species of mushrooms worldwide. Only 20-25% of mushrooms have been named, and 3% of these are poisonous. More than 95% of mushroom poisoning cases occur due to difficulties associated with the identification of mushroom species. Most of the fatal mushroom poisoning cases recorded to date have been related to the Amanita species. Until now, a case of fatal poisoning caused by Macrolepiota neomastoidea (M. neomastoidea) has not been reported in Asia. A 57-year-old male patient was admitted to the emergency room with nausea, vomiting, diarrhea, and abdominal pain. He reported ingesting wild mushrooms with his mother and sister about 2 days ago. His mother and sister were treated with only supportive care, but he was admitted to the intensive care unit and underwent liver transplantation due to acute liver failure. We are reporting a case of fatal M. neomastoidea intoxication from wild mushrooms, a rare case of mushroom poisoning.

Entities:  

Keywords:  Acute liver failure; Macrolepiotin; Mushrooms; Poisoning

Mesh:

Year:  2018        PMID: 29471607     DOI: 10.4166/kjg.2018.71.2.94

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  2 in total

1.  Macrolepiota in Korea: New Records and a New Species.

Authors:  Hae Jin Cho; Hyun Lee; Myung Soo Park; Changmu Kim; Komsit Wisitrassameewong; Abel Lupala; Ki Hyeong Park; Min Ji Kim; Jonathan J Fong; Young Woon Lim
Journal:  Mycobiology       Date:  2019-09-18       Impact factor: 1.858

2.  Demographic, clinical, and laboratory findings of mushroom-poisoned patients in Kermanshah province, west of Iran.

Authors:  Maryam Janatolmakan; Mohammad Rouhi Ganji; Touraj Ahmadi-Jouybari; Shahab Rezaeian; Mahnaz Ghowsi; Alireza Khatony
Journal:  BMC Pharmacol Toxicol       Date:  2022-09-26       Impact factor: 2.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.